This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Miller, D. K. Articles by Homan, S. M. Search for Related Content PubMed PubMed Citation Articles by Miller, D. K. Articles by Homan, S. M. Social Bookmarking                         What's this?

Determining Transition Probabilities

Confusion and Suggestions

Sharon M. Homan, PhD

Confusion regarding proper use of the terms rate and risk persists in the literature. This has implications for the proper modeling of prognosis and transition between health states in decision analysis and related techniques. The issue is complicated by the plethora of terms related to rate and risk. Although the suggestion to use the terms force and probability as substitutes for rate and risk has some appeal, the change in terminology by itself is unlikely to solve all the confusion or misuse of terms. This paper clarifies the proper definitions and estimations of rates and risks and suggests critical factors for the decision analyst to re member when using, modeling, or interpreting transition rates and risks. Key words: decision models; rate; risk; force; probability; transitions. (Med Decis Making 1994;14:52-58)

Medical Decision Making, Vol. 14, No. 1, 52-58 (1994)
DOI: 10.1177/0272989X9401400107


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. A.A. Fiddelers, C. D. Dirksen, J. C.M. Dumoulin, A. P.A. van Montfoort, J. A. Land, J. M. Janssen, J. L.H. Evers, and J. L. Severens Cost-effectiveness of seven IVF strategies: results of a Markov decision-analytic model Hum. Reprod., July 1, 2009; 24(7): 1648 - 1655. [Abstract] [Full Text] [PDF]

				E. Remak, C. Charbonneau, S. Negrier, S. T. Kim, and R. J. Motzer Economic Evaluation of Sunitinib Malate for the First-Line Treatment of Metastatic Renal Cell Carcinoma J. Clin. Oncol., August 20, 2008; 26(24): 3995 - 4000. [Abstract] [Full Text] [PDF]

				K. Dalziel and L. Segal Time to give nutrition interventions a higher profile: cost-effectiveness of 10 nutrition interventions Health Promot. Int., December 1, 2007; 22(4): 271 - 283. [Abstract] [Full Text] [PDF]

				M. Lamotte, L. Annemans, B. Bridgewater, S. Kendall, and M. Siebert A health economic evaluation of concomitant surgical ablation for atrial fibrillation Eur. J. Cardiothorac. Surg., November 1, 2007; 32(5): 702 - 710. [Abstract] [Full Text] [PDF]

				A. W. Kurian, R. N. Thompson, A. F. Gaw, S. Arai, R. Ortiz, and A. M. Garber A Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in Early HER2/neu-Positive Breast Cancer J. Clin. Oncol., February 20, 2007; 25(6): 634 - 641. [Abstract] [Full Text] [PDF]

				K. J. Smith, A. E. Barnato, and M. S. Roberts Teaching Medical Decision Modeling: A Qualitative Description of Student Errors and Curriculum Responses Med Decis Making, November 1, 2006; 26(6): 583 - 588. [Abstract] [PDF]

				K. Dalziel, L. Segal, and M. de Lorgeril A Mediterranean Diet Is Cost-Effective in Patients with Previous Myocardial Infarction J. Nutr., July 1, 2006; 136(7): 1879 - 1885. [Abstract] [Full Text] [PDF]

				N. J. Welton and A. E. Ades Estimation of Markov Chain Transition Probabilities and Rates from Fully and Partially Observed Data: Uncertainty Propagation, Evidence Synthesis, and Model Calibration Med Decis Making, November 1, 2005; 25(6): 633 - 645. [Abstract] [PDF]

				H-H Konig and J-C Barry Cost effectiveness of treatment for amblyopia: an analysis based on a probabilistic Markov model Br J Ophthalmol, May 1, 2004; 88(5): 606 - 612. [Abstract] [Full Text] [PDF]

				N J Cooper, A J Sutton, and K R Abrams Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section Statistical Methods in Medical Research, December 1, 2002; 11(6): 491 - 512. [Abstract] [PDF]

				Y. Yazdanpanah, G. Chene, E. Losina, S. J Goldie, L. D. Merchadou, S. Alfandari, G. R Seage III, L. Sullivan, C. Marimoutou, A D. Paltiel, et al. Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts Int. J. Epidemiol., August 1, 2001; 30(4): 864 - 871. [Abstract] [Full Text] [PDF]

				A. D. Paltiel and K. A. Freedberg The Cost-Effectiveness of Preventing Cytomegalovirus Disease in AIDS Patients Interfaces, May 1, 1998; 28(3): 34 - 51. [Abstract] [PDF]

				A. D. Paltiel, J. A. Scharfstein, G. R. Seage, E. Losina, S. J. Goldie, M. C. Weinstein, D. E. Craven, and K. A. Freedberg A Monte Carlo Simulation of Advanced HIV Disease: Application to Prevention of CMV Infection Med Decis Making, April 1, 1998; 18(2): S93 - S105. [Abstract] [PDF]

				K. A. Freedberg, J. A. Scharfstein, G. R. Seage III, E. Losina, M. C. Weinstein, D. E. Craven, and A. D. Paltiel The Cost-effectiveness of Preventing AIDS-Related Opportunistic Infections JAMA, January 14, 1998; 279(2): 130 - 136. [Abstract] [Full Text] [PDF]

				J. A. Scharfstein, A. D. Paltiel, and K. A. Freedberg The Cost-Effectiveness of Fluconazole Prophylaxis against Primary Systemic Fungal Infections in AIDS Patients Med Decis Making, October 1, 1997; 17(4): 373 - 381. [Abstract] [PDF]

				W. C. Black, R. F. Nease, and H. G. Welch Determining Transition Probabilities from Mortality Rates and Autopsy Findings Med Decis Making, February 1, 1997; 17(1): 87 - 93. [Abstract] [PDF]

				M. D. Danese, N. R. Powe, C. T. Sawin, and P. W. Ladenson Screening for Mild Thyroid Failure at the Periodic Health Examination: A Decision and Cost-effectiveness Analysis JAMA, July 24, 1996; 276(4): 285 - 292. [Abstract] [PDF]